A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

NCT05635747 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Boston Children's Hospital

Collaborators